Form 4: Strata Critical Medical Co-CEO Exercises Stock Options

Sentiment:

Insider Transaction Report 23 October 2025 4:06 PM

📋All filings for Blade Air Mobility, INC

Melissa M. Tomkiel, Co-CEO of Strata Critical Medical, Inc., exercised options to acquire 55,556 shares of Class A common stock at $0.18 per share.

Summary

Melissa M. Tomkiel, Co-CEO and General Counsel of Strata Critical Medical, Inc. (SRTA), reported an insider transaction.
On October 22, 2025, she exercised stock options to acquire 55,556 shares of Class A common stock.
The exercise price for these shares was $0.18 per share.
Following this transaction, her direct beneficial ownership of Class A common stock increased to 1,270,372 shares.
She now beneficially owns 304,738 stock options (right to buy) after exercising 55,556 options.

Sentiment

Score: 7

Explanation: The exercise of stock options by a Co-CEO to acquire a significant number of shares at a low price generally indicates management's confidence in the company's future performance and potential for stock appreciation.

Positives

The exercise of stock options by a Co-CEO to acquire shares indicates management's confidence in the company's future prospects.
The exercise price of $0.18 per share is relatively low, suggesting a potential gain for the insider if the stock price is higher, aligning management's interests with shareholders.

Future Outlook

Industry Context

Stakeholder Impact

Shareholders: May view the insider's increased ownership as a positive signal of confidence in the company's future, potentially influencing investor sentiment.

Key Dates

Date	Description
05/07/2021	Date stock options became exercisable.
10/22/2025	Date of stock option exercise and acquisition of Class A common stock.
10/23/2025	Date of filing signature.
07/28/2030	Expiration date of stock options.

Recommendation

hold

The exercise of stock options by a Co-CEO indicates management confidence, which is a positive signal. However, this Form 4 filing only reports a single insider transaction and does not provide sufficient financial or operational data to warrant a 'buy' or 'sell' recommendation. Investors should consider this information alongside comprehensive financial statements and broader market analysis.

Keywords

Strata Critical Medical, SRTA, Melissa M. Tomkiel, Form 4, Insider Transaction, Stock Option Exercise, Class A Common Stock, Co-CEO, General Counsel

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.